NCT05540899View on ClinicalTrials.gov

Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 8, 2023

Primary Completion Date

July 31, 2027

Study Completion Date

November 30, 2028

Conditions
Head and Neck CancerHead and Neck Squamous Cell CarcinomaSquamous Cell Carcinoma of the LarynxSquamous Cell Carcinoma of the OropharynxSquamous Cell Carcinoma of the Oral Cavity
Interventions
RADIATION

Hypofractionated Postoperative Radiotherapy

Hypofractionated Postoperative Radiation Therapy

Trial Locations (1)

17033

Milton S. Hershey Medical Center, Hershey

All Listed Sponsors
collaborator

RTOG Foundation, Inc.

OTHER

lead

American College of Radiology

OTHER

NCT05540899 - Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer | Biotech Hunter | Biotech Hunter